Pinney Associates

From TobaccoTactics
Share/Save/Bookmark
Jump to: navigation, search

Pinney Associates is an American health consultancy, founded in 1994 by John Pinney.[1]

Relationship with the Tobacco Industry

Image 1: Screengrab from pinneyassociates.com, taken November 2017, disclosingg that its harm reduction work is funded by a tobacco company

Reynolds American Funding Its Harm Reduction Work

From February 2015, Pinney Associates’ work on tobacco harm reduction has been exclusively funded by US tobacco company Reynolds American (RAI) (see image 1).[2][3]

The agreement between Pinney Associates and the tobacco company reportedly covers the development of reduced risk products (notably nicotine gum and e-cigarettes) and working on “policies that aim to reduce the harmful effects of tobacco”.[4]

At the time of the agreement, John Pinney, the founder of Pinney Associates said:

“Our overriding objective is to minimize the death and disease caused by conventional cigarette smoking as quickly as possible and we believe we have a powerful opportunity to advance this objective with these new relationships”[3]

Financial Interest in Nicotine Gum Marketed by Tobacco Company

Jack Henningfield, Pinney Associates’ Vice President Research, and leading expert on tobacco control and addiction, has disclosed that he shares a patent for a nicotine gum that is under license to Niconovum, a wholly-owned subsidiary of RAI.[5]

Affiliations

Pinney Associates staff have presented at the Global Tobacco and Nicotine Forum, a tobacco industry event, in 2016 and 2017.

TobaccoTactics Resources

Relevant Link

Pinney Associates website

Notes

  1. Pinney Associates, Our people: John Pinney, Founder and Chief Executive, undated, accessed November 2017
  2. Pinney Associates, Tobacco harm reduction, 2017, accessed November 2017
  3. 3.0 3.1 PR Newswire, PinneyAssociates and Subsidiary Enter into Product Development and Consulting Agreements with Subsidiaries of Reynolds American Inc., 19 February 2015, accessed November 2017
  4. M. Fekberbaum, Reynolds American delving deeper into nicotine gum business, The Washington Times, 19 February 2015, accessed November 2017
  5. J. Henningfield, Global Nicotine Reduction Strategy. Personal Insights on the View From FDA and the WHO TobReg Study Group, Presented at CORESTA Congress, Berlin, 11 October 2016, accessed November 2017